1
TITLE: Overall survival (OS) in the IMELDA randomized phase III trial of maintenance bevacizumab (BEV) with or without capecitabine (CAP) for HER2-negative metastatic breast cancer (mBC)
AUTHORS: Joseph Gligorov; Jose Bines; Emilio Alba; Giorgio Mustacchi; Saverio Cinieri; Vineet Gupta; Jean Yves Pierga; Hakan Bozcuk; Rabab Gaafar; Sudeep Gupta; Guillermo Lopez Vivanco; Xiaojia J Wang; Romulo Costa; Kadri Altundag; Ewa Chmielowska; Sabine de Ducla; Ulrich Freudensprung; Paulo Cortes; Dinesh Doval;
PUBLISHED: 2015, SOURCE: 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium in CANCER RESEARCH, VOLUME: 75, ISSUE: 9
INDEXED IN: WOS CrossRef
4
TITLE: Small Molecule-Mediated Activation of the Integrin CD11b/CD18 Reduces Inflammatory Disease
AUTHORS: Dony Maiguel; Mohd Hafeez Faridi; Changli L Wei; Yoshihiro Kuwano; Keir M Balla; Dayami Hernandez; Constantinos J Barth; Geanncarlo Lugo; Mary Donnelly; Ali Nayer; Luis F Moita ; Stephan Schuerer; David Traver; Phillip Ruiz; Roberto I Vazquez Padron; Klaus Ley; Jochen Reiser; Vineet Gupta;
PUBLISHED: 2011, SOURCE: SCIENCE SIGNALING, VOLUME: 4, ISSUE: 189
INDEXED IN: Scopus WOS CrossRef
5
TITLE: Drugs that simultaneously down-regulate IL-1β and TNF secretion significantly reduce inflammation in a rat model of antigen-induced arthritis  Full Text
AUTHORS: Rita Cascão; Bruno Vidal; Helena Raquel; Vineet Gupta; João E Fonseca; Luis F Moita;
PUBLISHED: 2011, SOURCE: Journal of Translational Medicine - J Transl Med, VOLUME: 9, ISSUE: Suppl 2
INDEXED IN: CrossRef